Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity

Chemosphere

Volumn 34, Issue 4, 1997, Pages 835-848

  Santodonato, Joseph ^a  

^a New York State Electric and Gas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON;

AIR POLLUTION; BREAST CANCER; CARCINOGENICITY; ESTROGEN METABOLISM; GENITAL TRACT CANCER; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; OCCUPATIONAL EXPOSURE; REVIEW; SOIL POLLUTION; WATER POLLUTION;

EID: 0031080629     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(97)00012-X     Document Type: Article

References (74)

1. 1. R. J. Miksicek, Estrogenic flavonoids: structural requirements for biological activity, Proc. Soc. Exptl. Biol. Med. 208, 44-50 (1995).
2. 2. V.C. Jordan, S. Mittal, B. Gosden, R. Koch and M.E. Lieberman, Structure-activity relationships of estrogens, Environ. Health Perspec. 61, 97-110 (1985).
3. 3. B. Zondek and E. Bergmann, LXXXIV. Phenol methyl ethers as estrogenic agents, Biochem. J. 32, 641-645 (1938).
4. 4. M.S. Wolff, P.G. Toniolo, E.W. Leel, M. Rivera, and N. Dubin, Blood levels of organochlorine residues and risk of breast cancer, J. Natl. Cancer Inst. 85, 648-652 (1993).
5. 5. J.D. McKinney and C.L. Waller, Polychlorinated biphenyls as hormonally active structural analogs, Environ. Health Perspec. 102, 290-297 (1994).
6. 6. N.M. Brown and C.A. Lamartiniere, Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat, Environ. Health Perspec. 103, 708-713 (1995).
7. 7. S. Jobling, T. Reynolds, R. White, M.G. Parker and J.P. Sumpter, A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic, Environ. Health Perspec. 103, 582-587 (1995).
8. 8. D.L. Davis, H.L. Bradlow, M. Wolff, T. Woodruff, D. G. Hoel and H. Anton-Culver, Medical Hypothesis: xenoestrogens as preventable causes of breast cancer, Environ. Health Perspec. 101, 372-377 (1993).
9. 9. J.A. McLachlan, Functional Toxicology: a new approach to detect biologically active xenobiotics, Environ. Health Perspec. 101, 386-387 (1993).
10. 10. C.A. Menzie, B.B. Potocki and J. Santodonato, Ambient concentrations and exposure to carcinogenic PAHs in the environment, Environ. Sci. Technol. 26, 1278-1283 (1992).
11. 11. J. Santodonato, P.H. Howard and D.K. Basu, Health and ecological assessment of polynuclear aromatic hydrocarbons, J. Environ. Pathol. Toxicol. 5, 1-364 (1981).
12. 12. International Agency for Research on Cancer, Polynuclear aromatic compounds, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 32, pp. 355-364, World Health Organization, Lyon, France (1983).
13. 13. S.S. Hecht, K. El-Bayoumy, A. Rivenson and S. Amin, Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene, Cancer Res. 54, 21-24 (1994).
14. 14. S. Hecht, S. Amin, J-M, Lin, A. Rivenson, C. Kurtzke and K. El-Bayoumy, Mammary carcinogenicity in female CD rats of a diol epoxide metabolite of fiuoranthene, a commonly occurring environmental pollutant, Carcinogenesis, 16, 1433-1435 (1995).
15. 15. E.L. Cavalieri, S. Higgenbotham, N.V.S .Rama Krishna, P.D. Devanesan, R. Todorovic, E.G. Rogan and S. Salmasi, Comparative dose-tumorigenicity studies of dibenzo[a,1]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,1]pyrene dihydrodiols in mouse skin and rat mammary gland, Carcinogenesis, 12, 1939-1944 (1991).
16. 16. C.W. Welsch, Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins, Cancer Res. 45, 3415-3443 (1985).
17. 17. C.W. Welsch and H. Nagasawa, Prolactin and murine mammary tumorigenesis: a review, Cancer Res. 37, 951-963 (1977).
18. 18. M. Neeman, G. Kartha, K. Go, J.P. Santodonato and O. Dodson-Simmons, Modified steroid hormones. VII. 4-fluoro-17β-estradiol: carbon-13 nuclear magnetic resonance, crystal and molecular structure, and biological activity, J. Med. Chem. 26, 465-469 (1983).
19. 19. P.W. Sylvester, C.F. Aylsworth, D.A. Van Vugt and J. Meites, Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats, Cancer Res. 43, 5342-5346 (1983).
20. 20. H.H. Inhoffen, The relationship of natural steroids to carcinogenic aromatic compounds, Prog. Organic Chem. (Edited by J.W. Cook), pp. 131-155, Academic Press, New York (1953).
21. 21. N.P. Buu-Hoi, New developments in chemical carcinogenesis by polycyclic hydrocarbons and related heterocycles: a review, Cancer Res. 24, 1511-1523 (1964).
22. 22. N.C. Yang, A.J. Castro, M. Lewis and T-W. Wong, Polynuclear aromatic hydrocarbons, steroids and carcinogenesis, Science, 134, 386-387 (1961).
23. 23. K. Peltonen and A. Dipple, Polycyclic aromatic hydrocarbons chemistry of DNA adduct formation, J. Occup. Environ. Med. 37, 52-58 (1995).
24. 24. D.H. Phillips and P.L. Grover, Polycyclic hydrocarbon activation: bay regions and beyond, Drug Metab. Rev. 26, 443-467 (1994).
25. 25. B.W. O'Malley, W.T. Schrader and M-J. Tsai, Molecular activation of steroid hormones, Adv. Exptl. Med. Biol. 196, 1-10 (1986).
26. 26. C.C. Landel, P.J. Kushner and G.L. Greene, Estrogen receptor accessory proteins: effects on receptor-DNA interactions, Environ. Health Perspec. 103 (Suppl 7), 23-28 (1995).
27. 27. S.W. Lucid and M.T. Shaw, Binding of dimethylbenzanthracene (DMBA) to estrogen receptor protein in rat uteri and mammary glands, Proc. Am. Assoc. Cancer Res. 16, 50 (1975).
28. 28. C.W. Heizman and H.I. Wyss, Comparison of the binding of 7,12-dimethylbenz[a]anthracene and estradiol-17β in the calf uterus cytosol, Steroids, 20, 499-514 (1972).
29. 29. D.D. Keightly and A.B. Okey, Effects of dimethylbenz[a]anthracene and dihydrotestosterone on estradiol-17β binding in rat mammary cytosol fraction, Cancer Res. 33, 2637-2642 (1973).
30. 30. D.D. Keightley and A.B. Okey, Effect of a carcinogenic oral dose of 7,12-dimethylbenz(a)anthracene on receptor binding of estradiol-17β in uterus and mammary tissue throughout lactation in the rat, Cancer Res. 34, 609-612 (1974).
31. 31. C. Pasqualini, A. Sarrieau, M. Dussaillant, M. Corbani, F. Bojda-Diolez, W. Rostene and B. Kerdelhue, Estrogen-like effects of 7,12-dimethylbenz(a)anthracene on the female rat hypothalamo-pituitary axis, J. Steroid Biochem. 36, 485-491 (1990).
32. 32. S. Schneider, V. Alks, C.E. Morreal, D.K. Sinha and T.L. Dao, Estrogenic properties of 3,9-dihydroxybenz[a]antnracene, a potential metabolite of benz[a]anthracene, J. Natl. Cancer Inst. 57, 1351-1354 (1976).
33. 33. Y.Y. Sheen, S.S. Kim and H.C. Yun, Effect of 3-methylcholanthrene on rat uterus: uterine growth and mechanism of action of 3-methylcholanthrene, Arch. Pharmacal Res. 16, 276-282 (1993).
34. 34. D.O. Toft and T.C. Spelsberg, A distinction between 3-methylcholanthrene and estrogen binding in the uterus, Cancer Res. 32, 2743-2746 (1972).
35. 35. R.H. Ebright, J.R. Wong and L.B. Chen, Binding of 2-hydroxybenzo[a]pyrene to estrogen receptors in rat cytosol, Cancer Res. 46, 2349-2351 (1986).
36. 36. E. Sulman and F. Sulman, The carcinogenicity of wood soot from the chimney of a smoked sausage factory, Cancer Res. 6, 366-367 (1946).
37. 37. W.C. Newman and R. Moon, Anti-uterotrophic response of immature mice to 3-methylcholanthrene, Nature, 221, 89 (1969).
38. 38. G.S. Kledzik, C.J. Bradley and J. Meites, Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs, Cancer Res. 34, 2953-2956 (1974).
39. 39. V.C. Jordan, Antiestrogenic and antitumor properties of tamoxifen in laboratory animals, Cancer Treat. Rep. 60, 1409-1419 (1976).
40. 40. V.C. Jordan, Laboratory models of breast cancer to aid the elucidation of antiestrogen action, J. Lab. Clin. Med. 109, 267-277 (1987).
41. 41. H. Lemon, Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine, Cancer Res. 35, 1341-1353 (1975).
42. 42. M.J. Brennan, Endocrinology in cancer of the breast, Am. J. Clin. Pathol. 64, 797-809 (1975).
43. 43. M. Sluyser, Steroid/thyroid receptor-like proteins with oncogenic potential: a review, Cancer Res. 50, 451-458 (1990).
44. 44. S. Bigelow and D. Nebert, The Ah regulatory gene product. Survey of nineteen polycyclic aromatic compounds' and fifteen benzo(a)pyrene metabolites' capacity to the cytosolic receptor, Toxicol. Lett. 10, 109-118 (1982).
45. 45. M. Denison and C. Wilkinson, Identification of the Ah receptor in selected mammalian species and induction of aryl hydrocarbon hydroxylase, Eur. J. Biochem. 147, 429-435 (1985).
46. 46. O. Pelkonen and H. Raunio, Individual Expression of carcinogen-metabolizing enzymes: cytochrome P4502A, J. Occup. Environ. Med. 37, 19-24 (1995).
47. 47. A.H. Conney, R.L. Chang, D.M. Jerina and S.-J. Caroline Wei, Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite, Drug Metab. Rev. 26, 125-163 (1994).
48. 48. A. Rannug, A.-K. Alexandrie, I. Persson and M. Ingelman-Sundberg, Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance, J. Occup. Environ. Med. 37, 25-36 (1995).
49. 49. J. Piskorska-Pliszczynska, B. Keys, S. Safe and M.S. Newman, The cytosolic binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons, Toxicol. Lett. 34, 67-74 (1986).
50. 50. K. Chaloupka, V. Krishnan and S. Safe, Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: role of the Ah receptor, Carcinogenesis, 13, 2233-2239 (1992).
51. 51. K. Chaloupka, N. Harper, V. Krishnan, M. Santostefano, L.V. Rodriguez and S. Safe, Synergistic activity of polynuclear aromatic hydrocarbon mixtures as aryl hydrocarbon (Ah) receptor agonists, Chem.-Biol. Interact. 89, 141-158 (1993).
52. 52. M. Christou, U. Savas, S. Schroeder, X. Shen, T. Thompson, M.N. Gould and C.R. Jefcoate, Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones, Molec. Cell. Endocrinol. 115, 41-50 (1995).
53. 53. J.K. Leighton, S. Canning, H.D. Guthrie and J.M. Hammond, Expression of cytochrome P450 1A1, an estrogen hydroxylase, in ovarian granulosa cells is developmentally regulated, J. Steroid Biochem. 52, 351-356 (1995).
54. 3H-estradiol and the excretion of endogenous estrone and estriol glucosiduronate in women with breast cancer, J. Clin. Endocrinol. 33, 138-144 (1971).
55. 55. J. Schneider, D. Kinne, A. Fracchia, V. Pierce, K.E. Anderson, H.L. Bradlow and J. Fishman, Abnormal oxidative metabolism of estradiol in women with breast cancer, Proc. Natl. Acad. Sci. USA 79, 3047-3051 (1982).
56. 56. M.P. Osborne, H.L. Bradlow, G.Y. Wong and N.T. Telang, Increase in the extent of estradiol 16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk, J. Natl. Cancer Inst. 85, 1917-1929 (1993).
57. 57. G.E. Swaneck and J. Fishman, Covalent binding of the endogenous estrogen, 16α-hydroxyestrone, to estradiol receptor in human breast cancer cells: characterization and intranuclear localization, Proc. Natl. Acad. Sci. USA 85, 7831-7835 (1988).
58. 58. N.T. Telang, A. Suto, G.Y. Wong, M.P. Osborne and H.L. Bradlow, Induction by estrogenmetabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells, J. Natl. Cancer Inst. 84, 634-638 (1992).
59. 59. H.L. Bradlow, D.L. Davis, G. Lin, D. Sepkovic and R. Tiwari, Effects of pesticides on the ratio of 16α/2-hydroxyestrone: a biologic marker of breast cancer risk, Environ. Health Perspec. 103(Suppl 7), 147-150 (1995).
60. 60. A. El Abed, B. Kerdelhue, M. Castanier and R. Scholler, Simulation of estradiol-17B secretion by 7,12-dimethylbenz(a)anthracene during mammary tumor induction in sprague-dawley rats, J. Steroid Biochem. 26, 733-738 (1987).
61. 61. B. Kerdelhue and A. El Abed, Inhibition of pre-ovulatory gonadotropin secretion and stimulation of prolactin secretion by 7,12-dimethylbenz(a)anthracene in sprague-dawley rats, Cancer Res. 39, 4700-4705 (1979).
62. 62. C. Pasqualini, F. Bojda and B. Kerdelhue, In vitro estrogen-like effects of 7,12-dimethylbenz(a)anthracene on anterior pituitary dopamine receptors of rats, Cancer Res. 48, 6434-6437 (1988).
63. 63. C. Pasqualini, F. Bojda, F. Gaudoux, B. Guibert, V. Leviel, E. Teissier, R. Rips and B. Kerdelhue, Changes in tuberoinfundibular dopaminergic neuron activity during the rat estrous cycle in relation to the prolactin surge: alteration by a mammary carcinogen, Neuroendocrinology, 48, 320-327 (1988).
64. 64. L.M. Garcia-Segura, F. Diolez-Bojda, V. Lenoir, F. Naftolin and B. Kerdelhue, Estrogen-like effects of the mammary carcinogen 7,12-dimethylbenz(a)anthracene on hypothalamic neuronal membranes. Brain Res. Bull. 28, 625-628 (1992).
65. 65. J.-O. Jansson, S. Ekberg, O. Isaksson, A. Mode and J.-A. Gustafsson, Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone, Endocrinology, 117, 1881-1889 (1985).
66. 66. R.C. Zangar, D.L. Springer and D.R. Buhler, Alterations in cytochrome P-450 levels in adult rats following neonatal exposure to xenobiotics, J. Toxicol. Environ. Health 38, 43-55 (1993).
67. 67. I. Fujita, R.K. Sindhu and Y. Kikkawa, Hepatic cytochrome P450 enzyme imprinting in adult rat by neonatal benzo[a]pyrene administration, Pediatric Res. 37, 646-651 (1995).
68. 68. F.G. Bock and T.L. Dao, Factors affecting the polynuclear hydrocarbon level in rat mammary glands, Cancer Res, 21, 1024-1029 (1961).
69. 69. T.L. Dao, F.G. Bock and S. Crouch, Level of 3-methylcholanthrene in mammary glands of rats after intragastric instillation of carcinogen, Proc. Soc. Exptl. Biol. Med. 102, 635-638 (1959).
70. 70. A.D. MacNicoll, G.C. Easty, A.M. Neville, P.L. Grover and P. Sims, Metabolism and activation of carcinogenic polycyclic hydrocarbons by human mammary cells, Biochem. Biophys. Res. Comm. 95, 1599-1606 (1980).
71. 71. S.S. Mane, D.M. Purnell and I.-C. Hsu, Genotoxic effects of five polycyclic aromatic hydrocarbons in human and rat mammary epithelial cells, Environ. Molec. Mutagen. 15, 78-82 (1990).
72. 72. D. Li, M. Wang, K. Dhingra and W.N. Hittelman, Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology, Cancer Res. 56, 287-293 (1996).
73. 73. S.M. Cohen and L.B. Ellwein, Cell proliferation in carcinogenesis, Science 249, 1007-1011, (1990).
74. 74. S. Preston-Martin, M.C. Pike, R.K. Ross, P.A. Jones and B.E. Henderson, Increased cell division as a cause of human cancer, Cancer Res. 50, 7415-7421 (1990).